Nanopep EPITALON® Spray in Human Research Cited in a 2026 FDA Briefing
The 2026 FDA briefing summarized published human data generated using Nanopep EPITALON® Solution-Spray, providing a direct product-specific link within the broader scientific literature on AEDG.